Abstract: A method for reducing the incidence of colic in a pediatric subject is presented, the method including administering to a subject a nutritional composition having about 1×103 to about 1×1012 cfu/100 kcal of LA metabolizing probiotic; up to about 7 g/100 kcal of a fat or lipid; up to about 5 g/100 kcal of a protein or protein equivalent source; about 0.06 g/100 kcal to about 1.5 g/100 kcal of enriched milk product; about 5 mg/100 kcal to about 90 mg/100 kcal of a source of long chain polyunsaturated fatty acids; and about 0.015 g/100 kcal to about 1.5 g/100 kcal of a prebiotic composition.

Abstract: The present invention relates to a novel process for collecting and isolating bacterial strains adhered to the intestinal mucosa by the endoscopic route by means of an innovative technique called “brushing”.

Abstract: There are described new bacterial strains, plasmids derived thereof, a gene sequence included in the plasmids encoding a phage resistance system protein, and a method to confer phage resistance to microorganism cultures.

Abstract: The disclosure refers to biologically pure cultures of two strains of Bifidobacterium Longum named W11 and W11a and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587. They are used as probiotics within preparations of pharmaceutical or alimentary products to help the gastrointestinal health and to prevent and treat the intestinal pathologies.

Abstract: The present invention refers to biologically pure cultures of two strains of Bifidobacterium Longum named W11 and W11a and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587, to their use as probiotics within preparations of pharmaceutical or alimentary type and to the preparations of pharmaceutical or alimentary type containing them useful to help the gastrointestinal health and to prevent and treat the intestinal pathologies.

Abstract: A growth medium adapted for the growth of a variety of different lactobacilli is provided. The medium is based on milk which is supplemented by at least four free amino acids, at least two ribonucleosides or other ribonulcleotide precursors, and iron. A variety of different Lactobacilli, particularly Lactobacilli belonging to Johnson's group A and B groups, are able to reproduce at rates approximately the same as milk supplemented with yeast extract. This medium when used in the production of dairy products that contain Lactobacilli does not contain the off-flavor of a fermented medium that had been supplemented with yeast extract.

Abstract: A method for the treatment of lactobacilli cultures is disclosed, characterized in that said cultures are added with an aliquot of culture supernatant of pathogenic microorganisms, or with the same pathogenic microorganisms optionally suitably inactivated. In particular, Lactobacillus gasseri BCCM LMG P-18137, Lactobacillus gasseri BCCM LMG P-17632 and Lactobacillus crispatus BCCM LMG P-17631.

Abstract: The present invention concerns Lactobacillus strains and pharmaceutical compositions containing them.

Abstract: Topical pharmaceutical compositions, suited for the use in gynecology and urology, comprise as active principles selected Lactobacillus strains isolated from vaginal or urologic habitat of asymptomatic patients.